PHARMACEUTICALS

Isomorphic Labs Nears $2 Billion Funding to Enhance Drug Discovery Efforts

1 hour ago
PHARMACEUTICALS

Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy Candidate

1 day ago
PHARMACEUTICALS

Isomorphic Labs Nears $2 Billion Funding Round Led by Thrive Capital

4 days ago
COMPANIES

Biosimilar ramp-up to drive growth for Biocon in FY27

4 days ago
COMPANIES

Son rise at Sun: Decoding the architecture of Dilip Shanghvi’s global empire

6 days ago
COMPANIES

Emcure doubling down on biosimilars pipeline: MD Satish Mehta

1 week ago
PHARMACEUTICALS

The story of global pharma giant Lupin; FarMart turns EBITDA profitable

1 week ago
Generics of Semaglutide Set to Transform India's Weight-Loss Market
Generics of Semaglutide Set to Transform India's Weight-Loss Market
1 month ago
India's Drug Regulator Pushes for Uniform Licensing Standards Across States
India's Drug Regulator Pushes for Uniform Licensing Standards Across States
1 month ago

Editor's pick

Sun-Organon buyout shows Indian Pharma's big hunger for overseas M&As — Here's a list of other major deals
COMPANIES

Sun-Organon buyout shows Indian Pharma's big hunger for overseas M&As — Here's a list of other major deals

2 weeks ago

Latest Briefs

Fast updates from the latest stories.

From almost nothing to a global pharma empire: The untold Lupin story
PHARMACEUTICALS +3
From almost nothing to a global pharma empire: The untold Lupin story
1 week ago
OxyContin maker Purdue Pharmas criminal sentence could be the last step before company dissolves
COMPANIES +2
OxyContin maker Purdue Pharmas criminal sentence could be the last step before company dissolves
2 weeks ago
Why Sun Pharma’s massive Organon buyout is winning over investors while Lupin, Biocon took time
COMPANIES +3
Why Sun Pharma’s massive Organon buyout is winning over investors while Lupin, Biocon took time
2 weeks ago
Dilip Shanghvi-led Sun Pharma's most expensive M&A deal signals fading allure of US generics business
COMPANIES +3
Dilip Shanghvi-led Sun Pharma's most expensive M&A deal signals fading allure of US generics business
2 weeks ago
Sun Pharma’s Organon buy took shape over three months of intense negotiations
COMPANIES +3
Sun Pharma’s Organon buy took shape over three months of intense negotiations
2 weeks ago
How big is Organon’s biosimilar push for Sun Pharma?
COMPANIES +4
How big is Organon’s biosimilar push for Sun Pharma?
2 weeks ago
Johnson & Johnson Reduces Drug Development Time with AI Innovations
TECHNOLOGY +2
Johnson & Johnson Reduces Drug Development Time with AI Innovations
2 weeks ago
Eyeing global heft, Indian cos open their purse strings for buyouts
COMPANIES +3
Eyeing global heft, Indian cos open their purse strings for buyouts
2 weeks ago

More Stories